Results 11 to 20 of about 1,384,561 (311)

Targeting mitochondrial quality control in muscle aging: Natural dietary products as potential interventions

Food Frontiers, 2023
Mitochondria are the main sources of energy production for muscle tissues, including skeletal, cardiac, or smooth muscle, to support their activities.
Qi Chen, Weisu Huang, Esra Capanoglu, Amel Thanina Amrouche, Baiyi Lu   +4 more
doaj   +1 more source

Riksmaten Adolescents 2016–17: A national dietary survey in Sweden – design, methods, and participation

Food & Nutrition Research, 2018
Background: Nationally representative information on food consumption data is essential to evaluate dietary habits, inform policy-making and nutritional guidelines, as well as forming a basis for risk assessment and identification of risk groups ...
Lotta Moraeus, Eva Warensjö Lemming, Ulla-Kaisa Koivisto Hursti, Marianne Arnemo, Jessica Petrelius Sipinen, Anna-Karin Lindroos   +5 more
doaj   +1 more source

A machine learning approach for identifying variables associated with risk of developing neutralizing antidrug antibodies to factor VIII

Heliyon, 2023
A key unmet need in the management of hemophilia A (HA) is the lack of clinically validated markers that are associated with the development of neutralizing antibodies to Factor VIII (FVIII) (commonly referred to as inhibitors).
Atul Rawal, Christopher Kidchob, Jiayi Ou, Osman N. Yogurtcu, Hong Yang, Zuben E. Sauna   +5 more
doaj   +1 more source

Low concentrations of perfluoroalkyl acids (PFAAs) in municipal drinking water associated with serum PFAA concentrations in Swedish adolescents

Environment International, 2023
While highly contaminated drinking water (DW) is a major source of exposure to perfluoroalkyl acids (PFAAs), the contribution of low-level contaminated DW (i.e. 
Jennifer Nyström-Kandola, Lutz Ahrens, Anders Glynn, Gunnar Johanson, Jonathan P. Benskin, Irina Gyllenhammar, Sanna Lignell, Carolina Vogs   +7 more
doaj   +1 more source

Benefit-Risk Assessment of Orlistat in the Treatment of Obesity [PDF]

Drug Safety, 2014
Orlistat, an inhibitor of intestinal lipase, has been available for the treatment of obesity for nearly two decades. In conjunction with a hypocaloric diet, orlistat treatment results in a placebo-subtracted reduction in body weight of around 3 kg at 1 year, and increases the likelihood of achieving clinically significant (≥5%) weight loss by around 20%
Sumithran, P, Proietto, J
openaire   +3 more sources

Patient-based benefit-risk assessment of medicines: development, refinement, and validation of a content search strategy to retrieve relevant studies

Journal of the Medical Library Association, 2021
Introduction: Poor indexing and inconsistent use of terms and keywords may prevent efficient retrieval of studies on the patient-based benefit-risk assessment (BRA) of medicines.
Hiba El Masri, Treasure M. McGuire, Christine Dalais, Mieke van Driel, Helen Benham, Samantha A. Hollingworth   +5 more
doaj   +1 more source

Relationship of Hearing Impairment in Patients with Lamivudine Therapy: A Systematic Review and Meta-analysis [PDF]

Journal of Clinical and Diagnostic Research, 2022
Introduction: Lifelong Antiretroviral Therapy (ARVT) in patients with Human Immunodeficiency Virus (HIV) infection damages cochlea. Hearing Loss (HL) has been reported with lamivudine therapy in both HIV and/or Hepatitis B Virus (HBV) infections.
Mahesh Namdeo Belhekar, Kalpesh K Joshi
doaj   +1 more source

A proposed methodology for prioritizing project effects to include in cost-benefit analysis using resilience, vulnerability and risk perception [PDF]

, 2014
Cost-benefit analysis (CBA) has emerged as one of the most widely used methodologies in environmental policy analysis, with many governments applying it in their decision-making procedures and laws.
Hanley, Nick, Torres Ortega, Saul, Ortega, Saúl, Nick Hanley, Simal, Pedro, Pedro Simal, Diaz Simal, Pedro, Saúl Ortega, Hanley, Nicholas David   +8 more
core   +1 more source

Benefit-risk assessment of vaccines

Vaccine
Benefit-risk assessment (BRA) is critical for decision-making throughout the vaccine life cycle. It requires scientific assessment of evidence to make an informed judgment on whether the vaccine has a favourable benefit-risk profile i.e. the benefits of the vaccine outweigh its risks for use in its intended indication. The assessment must also consider
Sonali Kochhar, Hector S. Izurieta, Rebecca E. Chandler, Adam Hacker, Robert T. Chen, Bennett Levitan   +5 more
openaire   +2 more sources

20210727_RAG_PRA_Health risk after flooding

, 2021
RAG PRA Health risk after  ...
Risk Assessment Group
core